Document is current
Any future updates will be listed below
-
Authors
Hickman, Elizabeth https://orcid.org/0000-0001-9038-9643
Seawoodharry, Mansha https://orcid.org/0000-0001-7005-1696
Gillies, Clare https://orcid.org/0000-0002-8417-9700
Khunti, Kamlesh https://orcid.org/0000-0003-2343-7099
Seidu, Samuel https://orcid.org/0000-0002-8335-7018
- License Information
-
More Information
Article History
Received: 18 January 2023
Accepted: 7 June 2023
First Online: 5 July 2023
Declarations
:
: Kamlesh Khunti has acted as a consultant and speaker for Novartis, Novo Nordisk, Sanofi-Aventis, Lilly, and Merck Sharp & Dohme. He has received grants in support of investigator and investigator-initiated trials from Novartis, Novo Nordisk, Sanofi-Aventis, Lilly, Pfizer, Boehringer Ingelheim, and Merck Sharp & Dohme.Samuel Seidu has received funds for research, consultancy to or honoraria from Boehringer Ingelheim, Lilly, Merck Sharp & Dohme Limited, Novartis Pharmaceuticals UK Ltd, Novo Nordisk Limited, Sanofi-Aventis, Amgen, Astra Zeneca, Janssen-Cilag Ltd, NAPP, and Takeda UK Ltd.Elizabeth Hickman, Mansha Seawoodharry, and Clare Gillies have no conflict of interest.
